ACL: ALCON INC Profile

Ticker

Advertisement

Choose a Broker

Dynamic view of the market

U.S. Markets open in 56 hrs, 24 mins

Symbol	Value	Change	Percentage Change
DJIA	11,496.57	49.91	0.44%
NASDAQ	2,282.78	-29.52	-1.28%
S&P 500	1,260.68	0.36	0.03%

ALCON INC

ACL

Stock price

166.91 4.37 2.69%

as of 04:01 PM EDT on 07/18/2008 in USD (NYSE Delay: 20 mins.)
Extended Hours

— — —

Analyst Consensus

Buy
Analyst Consensus

Strong Buy

Buy

Hold

Sell

Strong Sell
- Add to Portfolio
- Add to Alerts
Discuss: ACL

ALCON INC Profile

Alcon sees all, and hopes you can too. Through its Alcon Laboratories subsidiary, Alcon sells ophthalmic surgical and pharmaceutical products and consumer contact lens care products. It is the largest maker of equipment used for cataract removal and laser vision correction. Alcon's best known consumer brand is its Opti-Free line of contact lens solutions and related products. The company's pharmaceuticals include glaucoma treatments, anti-infectives, and allergy relievers. Founded in 1945, Alcon was acquired by Nestl� in 1977, but was spun off in 2002. Nestl� retained about three-quarters of the company but announced plans in 2008 to sell its share to Novartis.

Cary R. Rayment: CEO

B�sch 69

CH-6331 H�nenberg, Zug, Switzerland

http://www.alconlabs.com

Phone: +41-41-785-88-88

Fax: —

Sector: Healthcare Industry: Health Services

2007 Sales	2007 Sales Growth	2007 Net Income	2006 Employees
$5,599,600,000	14.4%	$1,586,400,000	13,500

Key Executives: ACL

Name	Title	Officer Since
Cary R. Rayment	CEO	5/1/05
Richard J. Croarkin	CFO	-
Elaine E. Whitbeck	General Counsel	-
Ed McGough	Senior VP, Subsidiary	-
Gerhard N. Mayr	Director	5/9/07
Joseph M. Weller	Director	5/2/06
Joanne Beck	General Manager	-
G. André Bens	—	-

View All Key Executives

Mr. Croarkin was named Senior Vice President, Finance and Chief Financial Officer of Alcon, Inc. and Alcon Laboratories, Inc. effective August 1, 2007. His global responsibilities include management of all financial functions for the Company as well as Information Technology, Investor Relations, Strategic Corporate Communications and coordination of the development and execution of corporate strategy. Mr. Croarkin joined Alcon from Nestle Waters... View Full Profile

Richard J. Croarkin

Mr. McGough was appointed Senior Vice President, Global Manufacturing and Technical Operations of Alcon Laboratories, Inc. in January 2008. He joined Alcon in 1991 as Manager, Quality Assurance and Regulatory Affairs at Alcon's precision device facility in Sinking Spring, Pennsylvania. Since that time, Mr. McGough has gained leadership experience through positions of increasing responsibility across manufacturing, including senior managerial... View Full Profile

Ed McGough

Ms. Whitbeck has served as Corporate Secretary and General Counsel of Alcon, Inc. since February 18, 2003. Ms. Whitbeck is Senior Vice President, Chief Legal Officer/General Counsel and Corporate Secretary for Alcon Laboratories, Inc. and its affiliates. Ms. Whitbeck has been with the Company for over 22 years. Ms. Whitbeck is responsible for all legal matters of the Company. Prior to joining the Company, Ms. Whitbeck was the Director of Legal... View Full Profile

Elaine E. Whitbeck

Mr. Mayr joined the Alcon, Inc. board in May 2007. Mr. Mayr began his career in 1972 with Eli Lilly & Company as a sales representative in West Germany. Since then, he has held several sales, marketing and general management positions in Europe, the Middle East and the United States. He became Vice President of European operations in 1986, progressively increasing his responsibilities in the following years and becoming President of Europe,... View Full Profile

Gerhard N. Mayr

Mr. Weller joined the Alcon, Inc. board in May 2006. Mr. Weller is the former Chairman and Chief Executive Officer of Nestle USA. He was also Chairman of Nestle Brands Company, Nestle Prepared Foods Company, Buitoni North America and Nestle Purina PetCare Company. He is a Nestle veteran of 37 years. Mr. Weller began his career in 1968 with the Carnation Company in sales (Nestle S.A. acquired Carnation in 1985). By 1981, Mr. Weller was named to... View Full Profile

Joseph M. Weller

Mr. Rayment has served as Chief Executive Officer of Alcon, Inc. since October 1, 2004, adding the responsibility of Chairman of the Board in May 2005. He has served as Chairman, President and Chief Executive Officer of Alcon Laboratories, Inc. since October 1, 2004. Prior to these promotions, Mr. Rayment served as Senior Vice President, Alcon United States from 2001 to 2004 (adding responsibility for Alcon Japan in 2004); Vice President and... View Full Profile

Cary R. Rayment

Joanne Beck, General Manager (Direktor).... View Full Profile

Joanne Beck

Joanne Beck, General Manager (Direktor).... View Full Profile

G. André Bens

Mr. Buehler was appointed Senior Vice President, Global Markets and Chief Marketing Officer of Alcon Laboratories, Inc. effective January 1, 2007. He served as Senior Vice President, Alcon United States and Chief Marketing Officer from February 2006 through December 2006. From 2004 to 2006, he was Senior Vice President, Alcon United States. From 2002 to 2004, Mr. Buehler was International Area Vice President with responsibility for the Company's... View Full Profile

Kevin J. Buehler

Dr. Cagle has served as Senior Vice President, Research & Development of Alcon Laboratories, Inc. since 1997, adding the responsibility of Chief Scientific Officer in February 2006. Previously, Dr. Cagle had served as Vice President, Development. Dr. Cagle joined the Company as Senior Scientist in Ophthalmic Microbiology in 1976 and has been continuously employed by the Company in various capacities, including Director, Ophthalmology and Vice... View Full Profile

Gerald D. Cagle

Mr. Polman joined the Alcon, Inc. board in May 2006. In February 2008, Mr. Polman was appointed Head of Zone Americas of Nestle. He served as Chief Financial Officer of Nestle from January 2006 to January 2008. Mr. Polman began his career in 1979 with Procter & Gamble in finance and acquired a broad executive experience through assignments in Belgium, Holland, France, Spain, the United Kingdom and the United States. He served as Group President... View Full Profile

Paul Polman

Mr. Castaner joined the Alcon, Inc. board in July 2001. He has served as Executive Vice President, Pharmaceutical and Cosmetic Products, Liaison with L'Oreal S.A., Human Resources and Corporate Affairs of Nestle since 1997. In 1987, Mr. Castaner was named Managing Director and in 1991 Vice President of the Board of Nestle Espana S.A., holding this position until his transfer to Switzerland and his promotion to Executive Vice President of Nestle... View Full Profile

Francisco Castaner

Mr. Castaner joined the Alcon, Inc. board in July 2001. He has served as Executive Vice President, Pharmaceutical and Cosmetic Products, Liaison with L'Oreal S.A., Human Resources and Corporate Affairs of Nestle since 1997. In 1987, Mr. Castaner was named Managing Director and in 1991 Vice President of the Board of Nestle Espana S.A., holding this position until his transfer to Switzerland and his promotion to Executive Vice President of Nestle... View Full Profile

Jacqualyn A. Fouse

Mr. de Vink joined the Alcon, Inc. board in March 2002. Mr. de Vink has served as Founding Partner of Blackstone Health Care Partners since April 2003. Prior to that, he was Chairman, International Health Care Partners from November 2000. Mr. de Vink was formerly Chairman, President and CEO of Warner-Lambert Company. Mr. de Vink is a member of the board of directors of Roche Holding AG and Flamel Technologies S.A. Mr. de Vink is also a member of... View Full Profile

Lodewijk J. R. de Vink

Martin Schneider, Attorney-in-Fact (Prokurist).... View Full Profile

Martin Schneider

Stefan Basler, Attorney-in-Fact (Prokurist).... View Full Profile

Stefan Basler

Dr. Bauer joined the Alcon, Inc. board in March 2002 and has served as Executive Vice President, Technical, Production, Environment and R&D of Nestle since May 2002. In February 2007, he was appointed Chief Technology Officer, Head of Innovation, Technology, R&D. Dr. Bauer began his career with Nestle in 1990 as Head of Nestle Research Center in Lausanne, Switzerland. In 1996, he became Head of R&D worldwide. In 1998, he moved to South Africa as... View Full Profile

Dr. Werner J. Bauer

Mr. Plaskett joined the Alcon, Inc. board in May 2003. In September 2003, the board affirmed Mr. Plaskett as the "audit committee financial expert." Since 1991, Mr. Plaskett has served as Chairman of Fox Run Capital Associates, a private consulting firm, focusing on financial advisory and consulting services for emerging companies. Previously, he was Chairman, President and Chief Executive Officer of Pan Am Corporation from 1988 to 1991, and... View Full Profile

Thomas G. Plaskett

Top Competitors: ACL

View Detailed Competitors Chart

Insider Trends: ACL
Sentiment for ACL is —
- 0M
- 2M
- 4M
- 6M
- Market Value of Insider Sales
- Market Value of Insider Purchases
Total dollar value of all insider purchases and sales over 12 months
View All Insider Sentiment

Insider Transactions: ACL

Date	Name	Shares	Transaction Type	Market Value
05/05/08	PLASKETT THOMAS G	3,000	Planned Sale	$475,000.00
04/29/08	RAYMENT CARY R	55,000	Planned Sale	$8.68 M
04/28/08	BUEHLER KEVIN	12,500	Planned Sale	$2.00 M

View All Insider Activity

Ownership Breakdown : ACL

Large Block Holder Type	Number
Institutions	393.00
Mutual Fund	579.00
Other Major	4.00

Full Details

Indices : ACL

Symbol	Name	Last Trade	Change

View all Indices that include ACL

Short Interest Volume: ACL

Data as of —

Current Short Interest Shares	1.09 B
Current Short Interest Ratio	2.90
Float	—

Short Interest as % of Float	—
Average Daily Volume	303,000.00
Outstanding Shares	298.07 M

Full Details

SEC Filings: ACL

Accepted Date	Description
07/14/2008	SEC Filing: Acquisition Statement
07/14/2008	SEC Filing: Foreign Issuer Report
07/08/2008	SEC Filing: Foreign Issuer Report

View all SEC Filings

Get Quote Details for:

- Help & Feedback

Market Movers

Related Resources

My Portfolios

AOL Real-Time Streaming Quotes

ALCON INC

ACL

Stock price

166.91 4.37 2.69%

as of 04:01 PM EDT on 07/18/2008 in USD (NYSE Delay: 20 mins.)
Analyst Consensus
- Strong Buy
- Buy
- Hold
- Sell
- Strong Sell
- Add to Portfolio
- Add to Alerts
Discuss: ACL

Quote Search Search the Web Search

More in Money & Finance
- Money
- Earnings
- Tech News
- Stock Screener
- Banking
- Checking Account
- Savings Account
- Credit Cards
- Credit Reports
- Identity Theft
- Debt Management
- Loans
- Auto Loan
- Personal Loans
- Mortgages
- Refinancing
- Taxes
- Online Tax Filing
- Tax Advice
- Tax Basics
- Tax Forms
- Audit
- Tax Credit
- Tax Deduction
- AMT
- Small Business
- BloggingStocks
- BloggingBuyouts
- Luxist
- TUAW
- DJIA
- Dow Jones Industrial Average
More Stock Research
Notices and Terms: Confirm all data with your broker before trading.

Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Financial.

© 2008 AOL LLC. All Rights Reserved.

AOL@Money © 2008 AOL LLC. All Rights Reserved.

Live Updates:

Ticker

Dynamic view of the market

ALCON INC

ACL

Stock price

Extended Hours

Analyst Consensus

ALCON INC Profile

Key Executives: ACL

Top Competitors: ACL

Insider Trends: ACL

Insider Transactions: ACL

Ownership Breakdown : ACL

Indices : ACL

Short Interest Volume: ACL

SEC Filings: ACL

Quote Details

Classic Chart

Advanced Chart BETA

Real-Time Headlines

Message Boards

Profile

Earnings Analysis

Event Calendar

Financials